Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Receivables - Other (2020 - 2025)

Historic Receivables - Other for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to $144000.0.

  • Rapid Micro Biosystems' Receivables - Other fell 3684.21% to $144000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $144000.0, marking a year-over-year decrease of 3684.21%. This contributed to the annual value of $100000.0 for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, Rapid Micro Biosystems' Receivables - Other stood at $144000.0, which was down 3684.21% from $100000.0 recorded in Q2 2025.
  • Rapid Micro Biosystems' 5-year Receivables - Other high stood at $1.1 million for Q3 2021, and its period low was $88000.0 during Q1 2022.
  • In the last 5 years, Rapid Micro Biosystems' Receivables - Other had a median value of $100000.0 in 2022 and averaged $257722.2.
  • Per our database at Business Quant, Rapid Micro Biosystems' Receivables - Other plummeted by 9061.03% in 2022 and then skyrocketed by 23300.0% in 2024.
  • Quarter analysis of 5 years shows Rapid Micro Biosystems' Receivables - Other stood at $396000.0 in 2021, then plummeted by 74.75% to $100000.0 in 2022, then changed by 0.0% to $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024, then soared by 44.0% to $144000.0 in 2025.
  • Its last three reported values are $144000.0 in Q3 2025, $100000.0 for Q2 2025, and $100000.0 during Q1 2025.